JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CHPM
5026
DELISTED
CHP Merger Corp. Class A Common Stock
CHPM
| $4K | ﹤0.01% |
400
| – | – |
2020 Q1
1 quarter
|
|
|
SOGO
5027
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
| $4K | ﹤0.01% |
901
-129,910
| -99% | -$461K |
2019 Q2
4 quarters
|
|
|
MCEP
5028
DELISTED
Mid-Con Energy Partners, LP
MCEP
| $4K | ﹤0.01% |
1,044
+992
| +1,908% | +$2.94K |
2015 Q3
19 quarters
|
|
|
VVNT.WS
5029
DELISTED
Vivint Smart Home, Inc. Warrants, each exercisable for one Class A Common Stock at an exercise price
VVNT.WS
| – | – |
0
| – | – |
2020 Q1
1 quarter
|
|
|
MLPI
5030
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
| $4K | ﹤0.01% |
374
-11,156
| -97% | -$126K |
2013 Q2
28 quarters
|
|
|
TLI
5031
DELISTED
Western Asset Corporate Loan Fund Inc.
TLI
| $4K | ﹤0.01% |
+500
| New | +$4.05K |
2020 Q2
0 quarters
|
|
|
CHAP
5032
DELISTED
Chaparral Energy, Inc.
CHAP
| $4K | ﹤0.01% |
6,900
-3,062
| -31% | -$1.61K |
2018 Q3
7 quarters
|
|
|
CVIA
5033
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $4K | ﹤0.01% |
8,723
-9,843
| -53% | -$5.38K |
2018 Q2
8 quarters
|
|
5034
Amplify Energy
AMPY
$181M
| $3K | ﹤0.01% |
2,055
-633,883
| -100% | -$759K |
2017 Q2
12 quarters
|
|
5035
Anixa Biosciences
ANIX
$103M
| $3K | ﹤0.01% |
958
-588
| -38% | -$1.22K |
2017 Q2
12 quarters
|
|
5036
VanEck Biotech ETF
BBH
$476M
| $3K | ﹤0.01% |
17
| – | – |
2015 Q1
21 quarters
|
|
5037
Celcuity
CELC
$3.53B
| $3K | ﹤0.01% |
394
-9,404
| -96% | -$66K |
2017 Q4
10 quarters
|
|
|
CHY
5038
Calamos Convertible and High Income Fund
CHY
$943M
| $3K | ﹤0.01% |
+300
| New | +$3.07K |
2020 Q2
0 quarters
|
|
5039
WisdomTree International High Dividend Fund
DTH
$628M
| $3K | ﹤0.01% |
85
-41,880
| -100% | -$1.32M |
2013 Q2
28 quarters
|
|
5040
First Trust Long/Short Equity ETF
FTLS
$2.58B
| $3K | ﹤0.01% |
+72
| New | +$2.88K |
2020 Q2
0 quarters
|
|
5041
Invesco CurrencyShares Australian Dollar Trust
FXA
$93M
| $3K | ﹤0.01% |
+50
| New | +$3.29K |
2020 Q2
0 quarters
|
|
5042
PUT
Heron Therapeutics
HRTX
$66M
| $3K | ﹤0.01% |
+200
| New | +$3.29K |
2020 Q2
0 quarters
|
|
5043
Invesco AI and Next Gen Software ETF
IGPT
$1.42B
| $3K | ﹤0.01% |
87
| – | – |
2019 Q2
4 quarters
|
|
|
BCIC
5044
BCP Investment Corp
BCIC
$85.3M
| $3K | ﹤0.01% |
300
-376
| -56% | -$4.24K |
2017 Q4
10 quarters
|
|
5045
DNA X Inc
SONM
$6.07M
| $3K | ﹤0.01% |
2
-10
| -83% | -$16K |
2019 Q2
4 quarters
|
|
|
SYBX
5046
DELISTED
Synlogic
SYBX
| $3K | ﹤0.01% |
91
-24,622
| -100% | -$787K |
2018 Q2
8 quarters
|
|
|
VIOT
5047
Viomi Technology
VIOT
$103M
| $3K | ﹤0.01% |
586
-13,999
| -96% | -$76.8K |
2019 Q4
2 quarters
|
|
5048
VanEck Vietnam ETF
VNM
$483M
| $3K | ﹤0.01% |
206
-126
| -38% | -$1.63K |
2013 Q2
28 quarters
|
|
5049
Direxion Daily FTSE China Bull 3X ETF
YINN
$526M
| $3K | ﹤0.01% |
13
| – | – |
2018 Q3
7 quarters
|
|
|
YI
5050
111 Inc
YI
$28.3M
| $3K | ﹤0.01% |
+46
| New | +$3.28K |
2020 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.